CXCL8 and posterior cortical atrophy: Below is an in-depth exploration of the molecular intricacies and therapeutic efficacy associated with inhibiting IL-8, CXCR1, and CXCR2 in PCa, shedding light on the promising strategies for providing alternative approaches to combating this complex disease [60].